{"symbol":"ABT","fiscalQuarter":"Q2-2012","reportDate":"2012-07-18","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2012","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 0.8%","keyNumbers":[{"metric":"EPS","actual":"$1.23","expected":"N/A","surprise":"+1.23%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS of $1.23, beating expectations, but the stock still fell by 0.8%. This decline may reflect investor concerns or broader market trends, as no revenue figures or guidance were provided to give further context.","metaDescription":"Abbott Laboratories (ABT) Q2 2012 earnings: EPS beat by 1.23%. Stock down 0.8%. Full breakdown."}}